English – Page 658 – TechStock²

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI

24 December 2025

Biotech News·FDA Updates·Financial Trends·Investment Analysis·Stock Market

Visa Stock News Today (NYSE: V): $500M Litigation Escrow Move, Holiday Spending Read-Through, and Analyst Forecasts for 2026

December 24, 2025 — Visa Inc. (NYSE: V) is in focus on Christmas Eve as investors digest a cluster of fresh developments that span legal risk management, U.S. holiday spending signals, and new-growth initiatives in AI-driven “agentic commerce” and stablecoin

24 December 2025

Analyst Forecasts·Financial Analysis·Investment Insights·Stock Market News

UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

NEW YORK — December 24, 2025 — UiPath Inc. (NYSE: PATH) is having a headline-grabbing Christmas Eve session, with shares climbing sharply after S&P Dow Jones Indices selected UiPath for inclusion in the S&P MidCap 400. In late-morning U.S. trading,

24 December 2025

Analyst Ratings·Investment News·Stock Market

GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

December 24, 2025 — GE Vernova Inc. (NYSE: GEV) has become one of the market’s most closely watched “power for AI” stocks in 2025, and Christmas Eve trading is arriving with the shares still in the spotlight after a dramatic

24 December 2025

Artificial Intelligence·Energy Sector·Financial Forecasts·Investment Analysis·Stock Market News

Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike, Inc. (NYSE: NKE) stock is getting a rare kind of holiday-season lift: a high-profile insider purchase. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, shares climbed roughly 4%–5% after filings showed Apple CEO Tim Cook—also Nike’s

24 December 2025

Financial News·Investing·Market Analysis·Nike·Stock Market

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot, Inc. (NYSE: HD) is trading through a shortened Christmas Eve session with investors juggling mixed signals: upbeat Wall Street ratings, cautious earnings-revision trends, and a steady drumbeat of institutional-position headlines. Meanwhile, the broader market’s “Santa rally” narrative is

24 December 2025

Analyst Insights·Financial News·Home Depot·Investing·Stock Market

Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

December 24, 2025 — Procter & Gamble (NYSE: PG) is ending 2025 in a familiar role for markets: a defensive bellwether that investors watch closely for clues about consumer demand, pricing power, and how quickly households are trading down—or trading

24 December 2025

CEO Changes·Company News·Investment Analysis·Market Trends·Stock Market

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the market spotlight on December 24, 2025, with the stock rallying sharply as investors digest a string of balance-sheet moves designed to extend liquidity, reduce leverage, and keep the company’s

24 December 2025

Analyst Forecasts·Electric Vehicles·Financial Updates·Investment News·Stock Market

Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck & Company, Inc. stock is ending 2025 on a strong note. On December 24, 2025, shares of Merck (MRK) pushed to a fresh 12‑month high around the $106 level, extending a powerful late‑year rally that has put the pharma

24 December 2025

Financial Analysis·Investment News·Pharmaceuticals·Stock Market

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy (HCM). By late morning, shares were trading around $26.37—up roughly

24 December 2025

Analyst Forecasts·Biotech News·Investment Strategies·Pharmaceutical Industry·Stock Market

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the

24 December 2025

Earnings Reports·Investing·Legal News·Pharmaceuticals·Stock Market

Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

NEW YORK — Citigroup, Inc. (NYSE: C) is closing out 2025 with a resurgence that has put C stock back on many investors’ watchlists. In the holiday-shortened session on Wednesday, Dec. 24, 2025, Wall Street traded close to record territory

24 December 2025

Banking·Financial News·Investment Analysis·Regulatory Updates·Stock Market